ASX:IVX

Invion Stock Forecast, Price & News

Add

Compare

Today's Range N/A

50-Day Range N/A

52-Week Range N/A

Volume471,000 shs

Average VolumeN/A

Market CapitalizationN/A

P/E RatioN/A

Dividend YieldN/A

BetaN/A

Receive IVX News and Ratings via Email

Sign-up to receive the latest news and ratings for Invion and its competitors with MarketBeat's FREE daily newsletter.

About Invion

Invion Limited, a clinical-stage life-sciences company, researches and develops photodynamic therapy for the treatment of various cancers in Australia. The company is developing IVX-PDT, a chlorophyll-based photosensitizer to treat skin cancers, as well as solid cancers, including lung, prostrate, ovarian, and mesothelioma cancers. It has a research and development agreement with Hudson Institute of Medical Research to collaborate on a range of research and development projects for the Photosoft technology for the treatment of a range of cancers; and research agreement with Peter MacCallum Cancer Centre to undertake pre-clinical and in-vitro studies on Invion's IVX-PDT Photodynamic therapy for ano-genital cancers, including penile and anal cancer. The company was incorporated in 2000 and is headquartered in Melbourne, Australia.

Shareholders Of Invion (ASX:IVX) Must Be Happy With Their 280% Total Return
June 16, 2021 | finance.yahoo.com

Weekly ASX small cap wrap: Who’s cruising ahead this week?
June 4, 2021 | msn.com

10 at 10: These ASX stocks have risen to the skies this morning
June 1, 2021 | msn.com

Weekly ASX Small Cap Wrap: Who’s taking a load off this week?
May 30, 2021 | msn.com

Invion led a group of ASX cancer stocks up after promising news
May 25, 2021 | msn.com

Check Up: Oneview leads healthcare sector after ‘investor awareness’ pact
March 19, 2021 | msn.com

Calculating The Fair Value Of Invion Limited (ASX:IVX)
March 1, 2021 | finance.yahoo.com

Invion Ltd.
September 13, 2020 | barrons.com

Invion (ASX:IVX) Is In A Strong Position To Grow Its Business
September 1, 2020 | finance.yahoo.com

IVIXF - Invion Limited
March 29, 2020 | finance.yahoo.com

See More Headlines

Industry, Sector and Symbol

Stock Exchange ASX
Industry Drug Manufacturers - Specialty & Generic
Sub-IndustryN/A
SectorMedical
Current SymbolASX:IVX
Previous Symbol
CUSIPN/A
CIKN/A
Webwww.inviongroup.com
Phone61 3 9081 6005
EmployeesN/A
Year FoundedN/A

Sales & Book Value

Annual Sales$2.33 million
Price / Sales0.00
Cash FlowN/A
Price / Cash Flow15.00
Book ValueA$0.00 per share
Price / BookN/A

Profitability

Debt

Price-To-Earnings

Miscellaneous

Outstanding SharesN/A
Market CapN/A
Next Earnings DateN/A
OptionableNot Optionable

MarketRank^™

Overall MarketRank^™

0.91 out of 5 stars

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for Invion.

4.5 Community Rank

Outperform Votes
Invion has received 19 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Invion has received 9 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Invion has received 67.86% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Invion and other stocks. Vote “Outperform” if you believe IVX will outperform the S&P 500 over the long term. Vote “Underperform” if you believe IVX will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
Invion does not currently pay a dividend.
Dividend Growth
Invion does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Invion insiders have not sold or bought any company stock.

0.0 Earnings and Valuation

See Top Rated MarketRank™ Stocks Here

Invion (ASX:IVX) Frequently Asked Questions

What stocks does MarketBeat like better than Invion?

Wall Street analysts have given Invion a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Invion wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Who are Invion's key executives?

Invion's management team includes the following people:

Mr. Thian Chew, Interim CEO & Exec. Chairman
Ms. Melanie Jaye Leydin C.A., B.Bus, CA, CFO & Company Sec. (Age 48)
Dr. Dean Naylor, Head of Intellectual Property Devel.

Who are some of Invion's key competitors?

Some companies that are related to Invion include Abacus Health Products (ABAHF), Acreage (ACRGF), Alliance Growers (ACG), Althea Group (AGH), Applied Biosciences (APPB), AusCann Group (AC8), Ayr Strategies (AYRSF), Bio-Rad Laboratories (BIO), Blueberries Medical (BBM), Can B (CANB), Cannara Biotech (LOVE), CannPal Animal Therapeutics (CP1), Cansortium (CNTMF), Chalice Brands (GLDFF) and Charlotte's Web (CWBHF).
View all of IVX's competitors.

What other stocks do shareholders of Invion own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Invion investors own include Denbury Resources (DNR), The Walt Disney (DIS), Carlisle Companies (CSL), Cyclone Metals Limited (CFE.AX) (CFE), Camtek (CAMT), Boston Properties (BXP), BioSpecifics Technologies (BSTC), BJ's Restaurants (BJRI), Banco Bradesco (BBD) and Aggreko (AGK).

What is Invion's stock symbol?

Invion trades on the ASX under the ticker symbol "IVX."

How much money does Invion make?

Invion has a market capitalization of $0.00 and generates $2.33 million in revenue each year.

What is Invion's official website?

The official website for Invion is www.inviongroup.com.

How can I contact Invion?

The company can be reached via phone at 61 3 9081 6005.

This page was last updated on 9/23/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Your Ultimate Investing Toolkit

Just $1.00 for your first month.